Biological therapies for schizophrenia Flashcards
1
Q
What did the Cochrane review of typical anti-psychotics find? What makes it special?
A
A meta-analysis of 302 studies.
- Chlorpromazine reduces relapse in the short and medium term, but less in the long term.
- Improves functioning of patients.
- Leads to various side effects including movement disorders and lowered blood pressure.
2
Q
What did the Cochrane review of clozapine vs typical anti-psychotics find? What makes it special?
A
A meta-analysis of 52 randomised control trials.
- No significant difference in regards to ability to work.
- Fewer relapses with clozapine.
- 34% of treatment resistant patients had a clinical improvement with clozapine.
- Clozapine led to more blood problems than typical anti-psychotics (3.5% vs 0%).
- Clozapine patients experience more drowsiness, but fewer adverse motor effects.
3
Q
What did Tharyan and Adams find with their Cochrane review in 2009? What makes it special?
A
A meta-analysis of 26 studies.
- More ECT patients improved than sham patients.
- ECT saw less relapses in the short term than sham ECT.
- No evidence that less relapses were maintained over medium and long term for ECT vs Sham.
- Results favoured drug treatment vs ECT.
- Some evidence that drug + ECT was better than solely drugs.
4
Q
A meta-analysis of 302 studies.
- Chlorpromazine reduces relapse in the short and medium term, but less in the long term.
- Improves functioning of patients.
- Leads to various side effects including movement disorders and lowered blood pressure.
A
Cochrane review of typical anti-psychotics.
5
Q
A meta-analysis of 52 randomised control trials.
- No significant difference in regards to ability to work.
- Fewer relapses with clozapine.
- 34% of treatment resistant patients had a clinical improvement with clozapine.
- Clozapine led to more blood problems than typical anti-psychotics (3.5% vs 0%).
- Clozapine patients experience more drowsiness, but fewer adverse motor effects.
A
Cochrane review of clozapine vs typical anti-psychotics.
6
Q
A meta-analysis of 26 studies.
- More ECT patients improved than sham patients.
- ECT saw less relapses in the short term than sham ECT.
- No evidence that less relapses were maintained over medium and long term for ECT vs Sham.
- Results favoured drug treatment vs ECT.
- Some evidence that drug + ECT was better than solely drugs.
A
Tharyan and Adams (Cochrane review), 2009.